T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$2.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 3 |
Broadcom
AVGO
|
+$1.61B |
| 4 |
Tesla
TSLA
|
+$1.59B |
| 5 |
Sempra
SRE
|
+$1.26B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.14B |
| 2 |
Amazon
AMZN
|
+$2.54B |
| 3 |
AET
Aetna Inc
AET
|
+$1.44B |
| 4 |
Biogen
BIIB
|
+$1.4B |
| 5 |
Netflix
NFLX
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.6% |
| 2 | Healthcare | 16.34% |
| 3 | Financials | 16.13% |
| 4 | Consumer Discretionary | 14.78% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CETV
1276
DELISTED
Central European Media Enterprises Ltd
CETV
| $14.2M | ﹤0.01% |
3,389,452
+1,477,326
| +77% | +$6.69M |
|
1277
Appian
APPN
$2.57B
| $14.2M | ﹤0.01% |
563,953
+557,053
| +8,073% | +$16.9M |
|
|
BEAT
1278
DELISTED
BioTelemetry, Inc.
BEAT
| $14.2M | ﹤0.01% |
457,323
+11,068
| +2% | +$364K |
|
1279
BlackRock TCP Capital
TCPC
$343M
| $14.2M | ﹤0.01% |
996,483
| – | – |
|
|
ALDR
1280
DELISTED
Alder Biopharmaceuticals
ALDR
| $13.8M | ﹤0.01% |
1,084,303
+5,024
| +0.5% | +$72.7K |
|
1281
Cibus
CBUS
$123M
| $13.7M | ﹤0.01% |
20,811
-750
| -3% | -$780K |
|
|
VER
1282
DELISTED
VEREIT, Inc.
VER
| $13.6M | ﹤0.01% |
391,547
-7,383
| -2% | -$262K |
|
|
IRCP
1283
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
| $13.5M | ﹤0.01% |
1,301,071
-48,361
| -4% | -$561K |
|
1284
John B. Sanfilippo & Son
JBSS
$1.01B
| $13.4M | ﹤0.01% |
230,855
-2,451
| -1% | -$148K |
|
|
AKAO
1285
DELISTED
Achaogen Inc
AKAO
| $13.1M | ﹤0.01% |
1,010,008
+62,952
| +7% | +$714K |
|
1286
Floor & Decor
FND
$6.24B
| $13M | ﹤0.01% |
250,240
-191,755
| -43% | -$9.06M |
|
1287
Onto Innovation
ONTO
$20.6B
| $13M | ﹤0.01% |
484,642
+17,520
| +4% | +$469K |
|
1288
Fluor
FLR
$7.11B
| $13M | ﹤0.01% |
227,304
-3,320
| -1% | -$191K |
|
1289
AES
AES
$10.5B
| $12.7M | ﹤0.01% |
1,121,096
-8,600
| -0.8% | -$93.5K |
|
1290
Telecom Argentina
TEO
$5.78B
| $12.7M | ﹤0.01% |
405,945
+17,902
| +5% | +$630K |
|
1291
Axalta
AXTA
$7.98B
| $12.6M | ﹤0.01% |
418,101
-1,313,466
| -76% | -$41.1M |
|
1292
Harley-Davidson
HOG
$2.9B
| $12.5M | ﹤0.01% |
290,702
| – | – |
|
1293
CALL
CVS Health
CVS
$123B
| $12.4M | ﹤0.01% |
200,000
| – | – |
|
1294
Helmerich & Payne
HP
$4.43B
| $12.4M | ﹤0.01% |
186,804
-1,400
| -0.7% | -$94.4K |
|
1295
RB Global
RBA
$15.6B
| $12.4M | ﹤0.01% |
394,387
-1,520,208
| -79% | -$48.4M |
|
1296
ManpowerGroup
MAN
$2.72B
| $12.4M | ﹤0.01% |
107,798
+2,350
| +2% | +$290K |
|
1297
FS Bancorp
FSBW
$326M
| $12.4M | ﹤0.01% |
463,026
+240
| +0.1% | +$6.64K |
|
|
AIV
1298
Aimco
AIV
$382M
| $12.1M | ﹤0.01% |
2,232,426
-16,785
| -0.7% | -$89.9K |
|
1299
Donaldson
DCI
$11.1B
| $12M | ﹤0.01% |
267,272
-580
| -0.2% | -$27.8K |
|
1300
CorVel
CRVL
$3.28B
| $11.9M | ﹤0.01% |
708,123
+15,444
| +2% | +$262K |
|
Similar funds
T. Rowe Price Associates's Q1 2018 Portfolio in Review
As of Q1 2018, T. Rowe Price Associates held 2,649 positions worth $629B, up 2.1% from $616B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q1 2018 filing shows 91 new, 1,526 increased, 842 reduced and 97 closed positions. Its largest new stake was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M. The largest sale was Apple, an estimated $6.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2018 buy was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M.
- T. Rowe Price Associates added most to Texas Instruments in Q1 2018, an estimated $2.29B increase.
- T. Rowe Price Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $6.14B.
- T. Rowe Price Associates fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $395M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $629B portfolio in Q1 2018.
- T. Rowe Price Associates opened 91 new positions and closed 97 in Q1 2018.
- T. Rowe Price Associates's portfolio value rose 2.1% quarter-over-quarter to $629B.
Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.